VANGUARD GROUP INC 13D and 13G filings for Royalty Pharma plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-30 3:48 pm Sale | 2025-09-30 | 13G | ROYALTY PHARMA PLC SHS RPRX | VANGUARD GROUP INC | 10,936,538 2.520% | -27,060,984 (-71.22%) | Filing |
| 2024-02-13 5:13 pm Purchase | 2023-12-29 | 13G | ROYALTY PHARMA PLC SHS RPRX | VANGUARD GROUP INC | 37,997,522 8.540% | 2,369,731 (+6.65%) | Filing |
| 2023-02-09 11:32 am Purchase | 2022-12-30 | 13G | ROYALTY PHARMA PLC SHS RPRX | VANGUARD GROUP INC | 35,627,791 8.080% | 5,991,226 (+20.22%) | Filing |
| 2022-02-10 08:37 am Purchase | 2021-12-31 | 13G | ROYALTY PHARMA PLC SHS RPRX | VANGUARD GROUP INC | 29,636,565 6.900% | 29,636,565 (New Position) | Filing |